John Mcmurray
Professor
Department of Cardiovascular and Medical Sciences
University of Glasgow
United Kingdom
Biography
John McMurray was born in Enniskillen in the north of Ireland in 1958. He attended Manchester University from where he graduated Bsc (Hons) in 1980 and MB ChB (Hons) in 1983. He undertook a period of postgraduate research at the University of Dundee, with award of his research MD in 1990. He trained in Medicine and Cardiology in Manchester, Edinburgh, Dundee and Glasgow and was appointed as Consultant Cardiologist in Edinburgh in 1993 before moving to Glasgow in 1995. He is now Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. He is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences. He has lectured widely and won several awards, including the Stokes Medal of the Irish Cardiac Society. In June 2015, Professor John McMurray and Professor Salim Yusuf (McMaster University, Hamilton Ontario, Canada) were jointly awarded the 8th Arrigo Recordati International Prize for Scientific Research (for outstanding contributions in secondary prevention and risk reduction strategies in patients with cardiovascular diseases). Professor McMurray served as the inaugural Eugene Braunwald Scholar in Cardiovascular Disease at the Brigham and Women’s Hospital, Boston, and visiting Professor of Medicine, Harvard University, Boston, Massachusetts USA 2010/2011. He is immediate Past-President of the Heart Failure Association of the ESC.
Research Interest
His primary research interests are in heart failure, coronary heart disease, atrial fibrillation and the cardiovascular consequences of diabetes and chronic kidney disease, with a focus on clinical trials and epidemiology. Professor McMurray’s main research activity is clinical trials and he is, or was, the principal investigator, member of the executive committee or steering committee member in a number of large trials in heart failure, other cardiovascular diseases, renal disease and diabetes. He has also participated in many data monitoring/safety committees. He chairs the event adjudication group at Glasgow University which has served as the endpoint committee for many trials. Professor McMurray has been a member and chair of many guideline committees. He was the lead author of the World Health Organization and first Scottish Intercollegiate Guidelines Network Guidelines on the Management of HF. In addition he was a member of the 2008 ESC HF Guidelines Task Force, and Chair of the 2012 Task Force and member of the 2013 American College of Cardiology/American Heart Association HF Guidelines Committee and the 2014 National Institute for Health and Care Excellence (NICE) Acute HF Guideline Committee. He is a member of NICE Appraisal Committee A. He is a member of the editorial board of the New England Journal of Medicine and sits on the editorial board of several leading cardiovascular journals, including the European Heart Journal (where he is an Associate Editor) and Circulation. In 2013, Professor McMurray was identified as one of the 400 most influential biomedical researchers in the world and the only cardiovascular researcher on this list from the UK (Boyack KW, Klavans R, Sorensen AA, Ioannidis JP. A list of highly influential biomedical researchers,1996-2011. Eur J Clin Invest. 2013; 43:1339-65). He has also been included in the 2014 and 2016 Highly Cited Researchers listing and one of The World's Most Influential Scientific Minds: 2014 by Thomson Reuters. Research: Heart Failure and Cardiovascular Trials CVD and Diabetes Trials
Publications
-
Mogensen, U. M. et al. (2017) Type of atrial fibrillation and clinical outcomes in patients with heart failure and reduced ejection fraction. Journal of the American College of Cardiology, (Accepted for Publication)
-
Olivier, A. et al. (2017) Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: insight from the EMPHASIS-HF trial. European Journal of Heart Failure, 19(9), pp. 1186-1197. (doi:10.1002/ejhf.792) (PMID:28303624)
-
Cotter, G. et al. (2017) Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? European Journal of Heart Failure, (doi:10.1002/ejhf.889) (PMID:28871621)